Background and Purpose Population study on relationship between nontuberculous mycobacterial (NTM) infection and respiratory failure (RF) is limited. This study evaluated the RF risk, including acute respiratory failure (ARF), chronic respiratory failure (CRF) and ARF on CRF, in patients with NTM infection in Taiwan. Methods We used the National Health Insurance Research Database of Taiwan to identify 3864 newly diagnosed NTM patients (NTM cohort) from 1999 to 2009, and 15456 non-NTM patients (non-NTM cohort), frequency matched by demographic status for comparison. Incidence and hazard of developing RF were measured by the end of 2010. Results The incidence rate of RF was 4.31-fold higher in the NTM cohort than in the non-NTM cohort (44.0 vs.10.2 per 1000 person-years), with an adjusted hazard ratio (HR) of 3.11 (95% CI: 2.73–3.54). The cumulative proportional incidence of RF was 10% higher in the NTM cohort than in the non-NTM cohort (P<0.0001). The RF risk was much greater within 6 months after the diagnosis of NTM infection with a HR of 7.45 (95% CI = 5.50–10.09). Age-specific comparison showed that the younger NTM patients had a higher HR of RF than the elderly NTM patients (HR: 4.42, 95% CI: 3.28–5.96 vs. HR: 2.52, 95% CI: 2.17–2.92). Comorbidity increased the risk of RF in both cohorts, particularly in those with chronic obstructive pulmonary disease. Conclusion Our study suggests patients with NTM infection are at a high risk of RF. The risk appears much greater soon after patients diagnosed with NTM infection.
References
[1]
Billinger ME, Olivier KN, Viboud C, de Oca RM, Steiner C, et al. (2009) Nontuberculous mycobacteria-associated lung disease in hospitalized persons, United States, 1998–2005. Emerg Infect Dis 15: 1562–1569. doi: 10.3201/eid1510.090196
[2]
Ringshausen FC, Apel RM, Bange FC, de Roux A, Pletz MW, et al. (2013) Burden and trends of hospitalisations associated with pulmonary non-tuberculous mycobacterial infections in Germany, 2005–2011. BMC Infect Dis 13: 231. doi: 10.1186/1471-2334-13-231
[3]
Huang WC, Chiou CS, Chen JH, Shen GH (2010) Molecular epidemiology of Mycobacterium abscessus infections in a subtropical chronic ventilatory setting. J Med Microbiol 59: 1203–1211. doi: 10.1099/jmm.0.020586-0
[4]
Shu CC, Lee CH, Wang JY, Jerng JS, Yu CJ, et al. (2008) Nontuberculous mycobacteria pulmonary infection in medical intensive care unit: the incidence, patient characteristics, and clinical significance. Intensive Care Med 34: 2194–2201. doi: 10.1007/s00134-008-1221-6
[5]
Ringshausen FC, de Roux A, Pletz MW, Hamalainen N, Welte T, et al. (2013) Bronchiectasis-associated hospitalizations in Germany, 2005–2011: a population-based study of disease burden and trends. PLoS ONE 8: e71109. doi: 10.1371/journal.pone.0071109
[6]
Wallace JM, Hannah JB (1988) Pulmonary disease at autopsy in patients with the acquired immunodeficiency syndrome. West J Med 149: 167–171.
[7]
Huang JH, Kao PN, Adi V, Ruoss SJ (1999) Mycobacterium avium-intracellulare pulmonary infection in HIV-negative patients without preexisting lung disease: diagnostic and management limitations. Chest 115: 1033–1040. doi: 10.1378/chest.115.4.1033
[8]
Kim TS, Koh WJ, Han J, Chung MJ, Lee JH, et al. (2005) Hypothesis on the evolution of cavitary lesions in nontuberculous mycobacterial pulmonary infection: thin-section CT and histopathologic correlation. AJR Am J Roentgenol 184: 1247–1252. doi: 10.2214/ajr.184.4.01841247
[9]
Jeong YJ, Lee KS, Koh WJ, Han J, Kim TS, et al. (2004) Nontuberculous mycobacterial pulmonary infection in immunocompetent patients: comparison of thin-section CT and histopathologic findings. Radiology 231: 880–886. doi: 10.1148/radiol.2313030833
[10]
Moore EH (1993) Atypical mycobacterial infection in the lung: CT appearance. Radiology 187: 777–782.
[11]
Sue DYLD, editor (2008) Respiratory failure. 3rd ed. New York, NY: Lange Medical Books/McGraw Hill. 247–313 p.
[12]
Kohno S, Seki M, Takehara K, Yamada Y, Kubo K, et al. (2013) Prediction of requirement for mechanical ventilation in community-acquired pneumonia with acute respiratory failure: a multicenter prospective study. Respiration 85: 27–35. doi: 10.1159/000335466
[13]
Behrendt CE (2000) Acute respiratory failure in the United States: incidence and 31-day survival. Chest 118: 1100–1105. doi: 10.1378/chest.118.4.1100
Gong MN, Thompson BT, Williams P, Pothier L, Boyce PD, et al. (2005) Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion. Crit Care Med 33: 1191–1198. doi: 10.1097/01.ccm.0000165566.82925.14
[16]
Lewandowski K (2003) Contributions to the epidemiology of acute respiratory failure. Crit Care 7: 288–290.
[17]
Franca SA, Toufen C Jr, Hovnanian AL, Albuquerque AL, Borges ER, et al.. (2011) The epidemiology of acute respiratory failure in hospitalized patients: a Brazilian prospective cohort study. J Crit Care 26: 330 e331–338.
[18]
Orsini J, Ahmad N, Butala A, Flores R, Tran T, et al. (2013) Etiology and Outcome of Patients with HIV Infection and Respiratory Failure Admitted to the Intensive Care Unit. Interdiscip Perspect Infect Dis 2013: 732421. doi: 10.1155/2013/732421
Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association. Am J Respir Crit Care Med 156: S1–25.
[21]
Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, et al. (2007) An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175: 367–416. doi: 10.1164/rccm.200604-571st
[22]
Andrejak C, Nielsen R, Thomsen VO, Duhaut P, Sorensen HT, et al. (2013) Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis. Thorax 68: 256–262. doi: 10.1136/thoraxjnl-2012-201772
[23]
Booth CM, Rapoport B (2011) Uptake of novel medical therapies in the general population. Curr Oncol 18: 105–108. doi: 10.3747/co.v18i3.858
[24]
Booth CM, Mackillop WJ (2008) Translating new medical therapies into societal benefit: the role of population-based outcome studies. JAMA 300: 2177–2179. doi: 10.1001/jama.300.18.2177
[25]
Carol J, Buck BMSCPC, editor (2001) ICD-9-CM Volumes 1, 2, 3 and 2001 HCPCS. Philadelphia: W.B. Saunders: 298–299.
[26]
Lee MR, Yang CY, Chang KP, Keng LT, Yen DH, et al. (2013) Factors associated with lung function decline in patients with non-tuberculous mycobacterial pulmonary disease. PLoS ONE 8: e58214. doi: 10.1371/journal.pone.0058214
[27]
Miravitlles M, Espinosa C, Fernandez-Laso E, Martos JA, Maldonado JA, et al. (1999) Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD. Chest 116: 40–46. doi: 10.1378/chest.116.1.40
[28]
Kubo K, Yamazaki Y, Masubuchi T, Takamizawa A, Yamamoto H, et al. (1998) Pulmonary infection with Mycobacterium avium-intracellulare leads to air trapping distal to the small airways. Am J Respir Crit Care Med 158: 979–984. doi: 10.1164/ajrccm.158.3.9802042
[29]
Lee AR, Lee J, Choi SM, Seong MW, Kim SA, et al. (2013) Phenotypic, immunologic, and clinical characteristics of patients with nontuberculous mycobacterial lung disease in Korea. BMC Infect Dis 13: 558. doi: 10.1186/1471-2334-13-558
[30]
Koh WJ, Kwon OJ, Lee KS (2002) Nontuberculous mycobacterial pulmonary diseases in immunocompetent patients. Korean J Radiol 3: 145–157. doi: 10.3348/kjr.2002.3.3.145
[31]
Prince DS, Peterson DD, Steiner RM, Gottlieb JE, Scott R, et al. (1989) Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med 321: 863–868. doi: 10.1056/nejm198909283211304
[32]
Systrom DM, Wittram C (2005) Case records of the Massachusetts General Hospital. Case 9-2005. A 67-year-old man with acute respiratory failure. N Engl J Med 352: 1238–1246. doi: 10.1056/nejmcpc059003
[33]
Shu CC, Lee CH, Hsu CL, Wang JT, Wang JY, et al. (2011) Clinical characteristics and prognosis of nontuberculous mycobacterial lung disease with different radiographic patterns. Lung 189: 467–474. doi: 10.1007/s00408-011-9321-4
[34]
Yeh JJ, Wang YC, Sung FC, Chou CY, Kao CH. (2014) Nontuberculosis Mycobacterium Disease is a Risk Factor for Chronic Obstructive Pulmonary Disease: A Nationwide Cohort Study. Lung. [Epub ahead of print].
[35]
Shaaban H, Layne T, Sensakovic JW, Boghossian J (2013) Mycobacterium kansasii septicemia in an AIDS patient complicated by acute respiratory distress syndrome and acute liver failure. Int J STD AIDS.
[36]
Babalik A, Kuyucu T, Ordu EN, Ernam D, Partal M, et al. (2012) Non-tuberculous mycobacteria infection: 75 cases. Tuberk Toraks 60: 20–31. doi: 10.5578/tt.2543
[37]
Kazumi Y, Murase Y, Ishii K, Maeda S (2013) [The outbreak of nosocomial infection by Mycobacterium cheolnae chemovar niacinogenes and the cause of its spread]. Kansenshogaku Zasshi 87: 424–430.
[38]
Zheng C, Fanta CH (2013) Non-tuberculous mycobacterial pulmonary infection in the immunocompetent host. QJM 106: 307–315. doi: 10.1093/qjmed/hct022
[39]
Yamazaki Y, Kubo K, Fujimoto K, Matsuzawa Y, Sekiguchi M, et al. (2000) Pulmonary function tests of Mycobacterium avium-intracellulare infection: correlation with bronchoalveolar lavage fluid findings. Respiration 67: 46–51. doi: 10.1159/000029462
[40]
Ding LW, Lai CC, Lee LN, Hsueh PR (2006) Disease caused by non-tuberculous mycobacteria in a university hospital in Taiwan, 1997–2003. Epidemiol Infect 134: 1060–1067. doi: 10.1017/s0950268805005698
[41]
Simons S, van Ingen J, Hsueh PR, Van Hung N, Dekhuijzen PN, et al. (2011) Nontuberculous mycobacteria in respiratory tract infections, eastern Asia. Emerg Infect Dis 17: 343–349. doi: 10.3201/eid1703.100604
